ArticleSensors (Basel, Switzerland)2024
Machine Learning-Based Approach towards Identification of Pharmaceutical Suspensions Exploiting Speckle Pattern Images.
Article in Sensors (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- New Insights on Hydration Monitoring in Elderly Patients by Interdigitated Wearable Sensors.Sensors (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Parenteral artificial nutrition (PAN) is a lifesaving medical treatment for many patients worldwide. Administration of the wrong PAN drug can lead to severe consequences on patients' health, including death in the worst cases. Thus, their correct identification, just before injection, is of crucial importance. Since most of these drugs appear as turbid liquids, they cannot be easily discriminated simply by means of basic optical analyses. To overcome this limitation, in this work, we demonstrate that the combination of speckle pattern (SP) imaging and artificial intelligence can provide precise classifications of commercial pharmaceutical suspensions for PAN. Towards this aim, we acquired SP images of each sample and extracted several statistical parameters from them. By training two machine learning algorithms (a Random Forest and a Multi-Layer Perceptron Network), we were able to identify the drugs with accurate performances. The novelty of this work lies in the smart combination of SP imaging and machine learning for realizing an optical sensing platform. For the first time, to our knowledge, this approach is exploited to identify PAN drugs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.